Cara Therapeutics Inc
(NASDAQ : CARA)

( )
CARA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.31%186.671.1%$893.59m
GILDGilead Sciences, Inc.
1.90%80.910.9%$837.97m
CELGCelgene Corporation
1.95%95.611.2%$687.44m
BIIBBiogen Inc.
2.80%292.781.2%$564.73m
JUNOJuno Therapeutics, Inc.
0.02%86.5813.5%$436.33m
REGNRegeneron Pharmaceuticals, Inc.
2.55%323.862.7%$403.87m
VRTXVertex Pharmaceuticals Incorporated
5.27%165.901.9%$348.24m
ALXNAlexion Pharmaceuticals, Inc.
3.79%118.932.0%$257.26m
NKTRNektar Therapeutics
1.58%89.606.0%$256.22m
ILMNIllumina, Inc.
3.13%233.843.5%$231.09m
AAgilent Technologies, Inc.
0.03%70.701.5%$186.84m
BLUEBluebird Bio, Inc.
2.41%206.0516.1%$156.27m
INCYIncyte Corporation
3.06%87.802.5%$152.45m
EXASExact Sciences Corporation
-5.82%42.3726.0%$117.22m
BMRNBioMarin Pharmaceutical Inc.
-1.13%83.054.4%$116.68m

Company Profile

CARA Therapeutics, Inc. is a clinical-stage company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.